Stocksigma LogoStocksigma Logo

Blue Star Completes Sale of MedTech Business to Cyrix for Rs 40 Crores

Blue Star completed the slump sale of its subsidiary's MedTech business to Cyrix Healthcare for up to Rs 40 crores in cash, effective 1st Sep'26

Blue Star Completes Sale of MedTech Business to Cyrix for Rs 40 Crores

Blue Star Ltd 路 Others (Uncategorized) 路 02 Sept 2026, 10:23 pm

Blue Star Completes Sale of MedTech Business to Cyrix for Rs 40 Crores Blue Star completed the slump sale of its subsidiary's MedTech business to Cyrix Healthcare for up to Rs 40 crores in cash, effective 1st Sep'26. Consideration is payable in tranches, concluding 31st Mar'27. For the fiscal year ending 31st Mar'26, the divested MedTech division generated Rs 42.13 crores in revenue, representing 0.33% of Blue Star's consolidated income, and held a net worth of Rs 7.11 crores (0.21% of total). The transaction was executed to allow the company to refocus on its core strategic priorities.

Original exchange filing (PDF)

More announcements from Blue Star Ltd

All Blue Star Ltd announcements